| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.1 | 0.5 |